Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Brain Glioma”

479 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 479 results

Early research (Phase 1)Study completedNCT01171469
What this trial is testing

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Who this might be right for
Brain TumorGlioblastomaMedulloblastoma+2 more
Masonic Cancer Center, University of Minnesota 8
Early research (Phase 1)Study completedNCT02457845
What this trial is testing

HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors

Who this might be right for
Supratentorial Neoplasms, MalignantMalignant GliomaGlioblastoma+4 more
Gregory K. Friedman, MD 13
Early research (Phase 1)Study completedNCT02507583
What this trial is testing

Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma

Who this might be right for
Malignant GliomaNeoplasms
david andrews 33
Not applicableTemporarily pausedNCT05475522
What this trial is testing

Intraoperative Sonographically Versus Fluorescence-guided Resection of Contrast-enhancing Gliomas and Brain Metastases

Who this might be right for
Gliomas, MalignantMetastases to Brain
Sklifosovsky Institute of Emergency Care 134
Testing effectiveness (Phase 2)Study completedNCT01051557
What this trial is testing

Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00045110
What this trial is testing

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+6 more
National Cancer Institute (NCI) 136
Early research (Phase 1)Study completedNCT00626483
What this trial is testing

Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia

Who this might be right for
Malignant Neoplasms Brain
Gary Archer Ph.D. 34
Early research (Phase 1)Study completedNCT02323880
What this trial is testing

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

Who this might be right for
Malignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more
Children's Oncology Group 59
Early research (Phase 1)Study completedNCT00613054
What this trial is testing

Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Annick Desjardins 27
Early research (Phase 1)Not Yet RecruitingNCT07541781
What this trial is testing

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Who this might be right for
GliomaGlioblastomaRecurrent Glioma+2 more
Kailin Yang, MD, PhD 45
Early research (Phase 1)Looking for participantsNCT03423628
What this trial is testing

Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Who this might be right for
Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, Malignant+1 more
AstraZeneca 180
Testing effectiveness (Phase 2)Study completedNCT00079092
What this trial is testing

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Wake Forest University Health Sciences 18
Early research (Phase 1)Study completedNCT01475006
What this trial is testing

AMG 595 First-in-Human in Recurrent Gliomas

Who this might be right for
Advanced Malignant GliomaAnaplastic AstrocytomasGlioblastoma Multiforme
Amgen 32
Testing effectiveness (Phase 2)Study completedNCT00190723
What this trial is testing

LY317615 in Patients With Brain Tumors

Who this might be right for
Malignant Glioma
Eli Lilly and Company 120
Early research (Phase 1)Temporarily pausedNCT04222309
What this trial is testing

Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Who this might be right for
GliomaGlioma, MalignantGlioblastoma+4 more
Northwell Health 10
Early research (Phase 1)Study completedNCT00612638
What this trial is testing

Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas

Who this might be right for
GlioblastomaGliosarcoma
Duke University 96
Testing effectiveness (Phase 2)Study completedNCT00613093
What this trial is testing

Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic Glioma
Duke University 67
Early research (Phase 1)Ended earlyNCT01148966
What this trial is testing

Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
University of Washington 6
Early research (Phase 1)Study completedNCT00634231
What this trial is testing

A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors

Who this might be right for
Malignant GliomaRecurrent Ependymoma
Candel Therapeutics, Inc. 8
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Load More Results